Vimarsana
Biggest News Aggregation in the World

Matt Heck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Matt Heck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Matt Heck Today - Breaking & Trending Today

Zydus' biopharma arm acquires global proprietary rights for Progeria treatment - Vimarsana News

Zydus' biopharma arm acquires global proprietary rights for Progeria treatment

India Business News: Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition milestone in expandin

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals - Vimarsana News

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals

/PRNewswire/ -- Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), and Eiger...

'Feud' between 2 men allegedly led to deadly shooting of local 15-year-old girl; 2 more men charged – WHIO TV 7 and WHIO Radio - Vimarsana News

'Feud' between 2 men allegedly led to deadly shooting of local 15-year-old girl; 2 more men charged – WHIO TV 7 and WHIO Radio

Two more men are now facing charges in connection with the deadly shooting of a 15-year-old girl in Harrison Twp. late last year.

Source: whio.com
Zydus Life shares rise as US arm gains rights for rare paediatric disease drug - Vimarsana News

Zydus Life shares rise as US arm gains rights for rare paediatric disease drug

Zydus Lifesciences' arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease

Micah Ben David Naziri, at The Blogs - Vimarsana News

Micah Ben David Naziri, at The Blogs

The Marketplace of Ideas at The Times of Israel